PROS1突变位置对蛋白S缺乏症患者血栓形成风险的影响
Tereza Fenclova1,2, Miloslava Matyskova3, Dana Provaznikova2
1First Faculty of Medicine, Charles University, Prague, Czech Republic.
Research and practice in thrombosis and haemostasis
|June 29, 2023
概括
蛋白S的SHBG类区域的突变会增加遗传蛋白S缺乏症患者的血栓形成风险. 这种特定的突变位置是静脉血栓栓塞的独立风险因素.
科学领域:
- 遗传学 是一个遗传学.
- 血液学 血液学 血液学
- 分子生物学分子生物学
背景情况:
- 遗传性蛋白S缺乏是静脉血栓栓塞的已知危险因素.
- 关于蛋白质S中的特定突变位置如何影响血栓形成风险的数据有限.
研究的目的:
- 与其他区域相比,研究与蛋白S的性激素结合型全球蛋白 (SHBG) 类似区域的突变相关的血栓形成风险.
- 确定突变位置是否是血栓形成的独立风险因素.
主要方法:
- 在76名怀疑遗传蛋白S缺乏症的患者中,对PROS1基因进行基因分析.
- 统计分析,包括多变量二元逻辑回归和卡普兰-梅尔分析,以根据突变位置评估血栓形成风险.
- 将患者分为"SHBG区域"和"非SHBG"突变组.
主要成果:
- 在70名患者中发现了30种独特的突变,其中17种是错误的突变.
- 发现SHBG类区域的突变是血栓形成的独立风险因素 (OR,5.17;P = .02).
- 患有SHBG区域突变的患者在较年轻时经历了血栓事件 (无血栓症的平均存活时间为33年而不是47年).
结论:
- 蛋白质S的SHBG类区域中的Missense突变可能比蛋白质的其他地方的突变具有更高的血栓形成风险.
- 在SHBG类区域内的突变位置是S蛋白缺乏症患者血栓形成风险的重要因素.
- 建议对更大的队列进行进一步研究,以证实这些发现,因为该研究的样本大小有限.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
763
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
763
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
566
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
566
01:30Venous Thrombosis I: Introduction
13
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
13
01:29Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
01:29Factors Affecting Protein-Drug Binding: Patient-Related Factors
83
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
83
01:17Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K